- Home
- MYNZ vs IBG Comparison
MYNZ vs IBG Comparison
Compare MYNZ & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- IBG
- Stock Information
- Founded
- MYNZ 2021
- IBG 2018
- Country
- MYNZ Germany
- IBG Australia
- Employees
- MYNZ N/A
- IBG N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- MYNZ Health Care
- IBG Consumer Staples
- Exchange
- MYNZ Nasdaq
- IBG Nasdaq
- Market Cap
- MYNZ 11.2M
- IBG 9.6M
- IPO Year
- MYNZ 2021
- IBG 2024
- Fundamental
- Price
- MYNZ $4.83
- IBG $0.94
- Analyst Decision
- MYNZ Hold
- IBG Strong Buy
- Analyst Count
- MYNZ 2
- IBG 1
- Target Price
- MYNZ N/A
- IBG N/A
- AVG Volume (30 Days)
- MYNZ 135.3K
- IBG 185.0K
- Earning Date
- MYNZ 10-21-2024
- IBG 02-15-2025
- Dividend Yield
- MYNZ N/A
- IBG N/A
- EPS Growth
- MYNZ N/A
- IBG N/A
- EPS
- MYNZ N/A
- IBG N/A
- Revenue
- MYNZ $917,203.00
- IBG $3,147,763.00
- Revenue This Year
- MYNZ $21.95
- IBG N/A
- Revenue Next Year
- MYNZ $30.77
- IBG N/A
- P/E Ratio
- MYNZ N/A
- IBG N/A
- Revenue Growth
- MYNZ 16.23
- IBG N/A
- 52 Week Low
- MYNZ $0.18
- IBG $0.60
- 52 Week High
- MYNZ $7.95
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- MYNZ 53.87
- IBG N/A
- Support Level
- MYNZ $3.86
- IBG N/A
- Resistance Level
- MYNZ $6.81
- IBG N/A
- Average True Range (ATR)
- MYNZ 0.74
- IBG 0.00
- MACD
- MYNZ -0.09
- IBG 0.00
- Stochastic Oscillator
- MYNZ 32.88
- IBG 0.00
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.